Woonyoung Choi
Johns Hopkins University
H-index: 36
North America-United States
Top articles of Woonyoung Choi
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Association of Molecular Subtypes with Pathologic Response, PFS, and OS in a Phase II Study of COXEN with Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer | Clinical Cancer Research | Seth P Lerner David J McConkey Catherine M Tangen Joshua J Meeks Thomas W Flaig | 2024/1/17 |
Reply to Kentaro Inamura's Letter to the Editor re: Mingxiao Feng, Andres Matoso, Gabriel Epstein, et al. Identification of Lineage-specific Transcriptional Factor-defined … | European urology | Mingxiao Feng Andres Matoso Gabriel Epstein Megan Fong Yong Hyun Park | 2024/4 |
Re: Niraparib and Abiraterone Acetate for Metastatic Castration-resistant Prostate Cancer | European urology | Edward Lambert Morgan Rouprêt | 2024/1 |
Molecular subtyping and immunohistochemistry validation identifies muscle Invasive bladder cancer subgroups with poorer overall survival | Cancer Research | Jiarui Zhang Mingxiao Feng Neil Beeharry Shibu Thomas Ralph Wirtz | 2024/3/22 |
Molecular profile of bladder cancer progression to clinically aggressive subtypes | Charles C Guo Sangkyou Lee June G Lee Huiqin Chen Michael Zaleski | 2024/2/6 | |
Predicting clinical outcomes in the S1314-COXEN trial using a multimodal deep learning model integrating histopathology, cell types, and gene expression. | Bishoy Morris Faltas Zilong Bai Mohamed Osman Matthew Brendel Catherine Tangen | 2024/2/1 | |
Tumour tissue‐derived small extracellular vesicles reflect molecular subtypes of bladder cancer | Journal of Extracellular Vesicles | Liang Dong Mingxiao Feng Morgan D Kuczler Kengo Horie Chi‐Ju Kim | 2024/2 |
Loss of LPAR6 and CAB39L dysregulates the basal-to-luminal urothelial differentiation program, contributing to bladder carcinogenesis | Cell Reports | Sangkyou Lee Jolanta Bondaruk Yishan Wang Huiqin Chen June Goo Lee | 2024/5/28 |
Control of the Basal Molecular Subtype of Murine Bladder Cancer by Adaptive Immunity | Cancer Research | Burles Avner Johnson Mingxiao Feng Woonyoung Choi Gabriela Colocho Alyssa Arbuiso | 2023/4/4 |
MP14-16 LATE CELL CYCLE SIGNATURES STRATIFY GEMDOCE RESPONSES FOR BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER | The Journal of Urology | Andrew Gabrielson Gabriel Epstein Mingxiao Feng Sunil Patel Max Kates | 2023/4 |
Atezolizumab with platinum and etoposide chemotherapy followed by cystectomy for patients with localized small cell neuroendocrine bladder cancer. | Jean H Hoffman-Censits Burles Avner Johnson Noah M Hahn Woonyoung Choi Armine Smith | 2023/2/20 | |
Identification of lineage-specific transcriptional factor–defined molecular subtypes in small cell bladder cancer | European urology | Mingxiao Feng Andres Matoso Gabriel Epstein Megan Fong Yong Hyun Park | 2023/6/27 |
Comparison of clinicopathological characteristics, gene expression profiles, mutational analysis, and clinical outcomes of pure and mixed small‐cell carcinoma of the bladder | Archives of Breast Cancer | Saeed Arefanian Neda Mehradad Shahpar Haghighat Safa Najafi Mandana Ebrahimi | 2014/5/31 |
Identification of lineage-specific transcription factor defined subtypes in small cell/neuroendocrine bladder cancer. | Gastroenterology | Xiao Liu Jun Xu Sara Rosenthal Ling-juan Zhang Ryan McCubbin | 2020/5/1 |
A phase 1 trial of durvalumab in combination with Bacillus Calmette-Guerin (BCG) or external beam radiation therapy in patients with BCG-unresponsive non-muscle-invasive … | European urology | Noah M Hahn Michael A O'Donnell Jason A Efstathiou Marianna Zahurak Gary L Rosner | 2023/6/1 |
Combined Mek inhibition and Pparg activation Eradicates Muscle Invasive Bladder cancer in a Mouse Model of BBN-induced Carcinogenesis | bioRxiv | Tiffany Tate Sakina Assiz Plumber Hikmat Al-Ahmadie Xiaoi Chen Woonyoung Choi | 2023 |
A Molecular Inquiry into the Role of Antibody-Drug Conjugates in Bacillus Calmette-Guerin-exposed Non-muscle-invasive Bladder Cancer | EUROPEAN UROLOGY | Moritz J Reike Roy Adar Peter C Black Woonyoung Choi Kara Lombardo | 2022/2/1 |
Characterizing molecular subtypes of high-risk non-muscle-invasive bladder cancer in African American patients | Urologic Oncology: Seminars and Original Investigations | Sungyong You Minhyung Kim Steven Widen Alexander Yu Gloria C Galvan | 2022/9/1 |
Association of DNA damage response (DDR) gene mutations (mts) and response to neoadjuvant cisplatin-based chemotherapy (chemo) in muscle-invasive bladder cancer (MIBC) patients … | Gopa Iyer Catherine Tangen Michal Sarfaty Ashley Marie Regazzi I-Ling C Lee | 2022/6/1 | |
S1314 correlative analysis of ATM, RB1, ERCC2, and FANCC mutations and pathologic complete response (pT0) at cystectomy after neoadjuvant chemotherapy (NAC) in patients with … | Elizabeth R Plimack Catherine Tangen Melissa Plets Rutika Kokate Joanne Xiu | 2022/6/1 |
